Publications

A universal dual mechanism immunotherapy for the treatment of influenza virus infections

Xin Liu, Boning Zhang, Yingcai Wang, Hanan S. Haymour, Fenghua Zhang, Le-cun Xu, Madduri Srinivasarao, and Philip S. Low

Nature Communications, 2020


Principles in the design of ligand targeted cancer therapeutics and imaging agents

Madduri Srinivasarao, Chris V. Galliford, and Philip S. Low

Nature Reviews Drug Discovery, February 2015


Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate–targeted immunotherapy in hapten-immunized mice

Yingjuan Lu, Le-Cun Xu, Nikki Parker, Elaine Westrick, Joseph A. Reddy, Marilynn Vetzel, Philip S. Low, and Christopher P. Leamon

Molecular Cancer Therapeutics, December 2006


Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential

Yingjuan Lu, Fei You, Iontcho Vlahov, Elaine Westrick, Mingjin Fan, Philip S. Low, and Christopher P. Leamon

Molecular Pharmaceutics, 2007


Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters

Yong Gu Lee, Haiyan Chu, Yingjuan Lu, Christopher P. Leamon, Madduri Srinivasarao, Karson S. Putt, and Philip S. Low

Nature Communications, 2019